Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2007-08-17 | He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2008-07-21 | Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2009-07-29 | Dr. Birnbaum is a pharmacologist and, prior to his current role as a consultant to pharmaceutical companies, he served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation. |
| 2010-07-29 | He received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2011-07-29 | Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2012-07-27 | Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2013-02-05 | Jay Birnbaum (9) Director |
| 2013-07-29 | Dr. Birnbaum received a Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut. |
| 2014-07-29 | Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin... Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership. |
| 2014-11-07 | Dr. Birnbaum is a member of our Board of Directors. |
| 2015-06-08 | Dr. Birnbaum is a member of our Board of Directors. He beneficially owns 0 shares of common stock and 158,025 shares of common stock issuable upon the exercise of options that are exercisable within 60 days of May 21, 2015. |
| 2015-07-28 | Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology, Ph.D. in Pharmacology. Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership. |
| 2016-07-29 | Dr. Birnbaum is a pharmacologist... Education: B.S. in Biology, Ph.D. in Pharmacology... Special Knowledge, Skills, and Abilities: Extensive Knowledge of the Company’s Business, Pharmaceutical Background, Leadership. |
| 2017-07-27 | Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies in his area of expertise. He previously served as Vice President of Global Project Management at Novartis/Sandoz Pharmaceuticals Corporation, where he was responsible for the strategic planning and development of the company’s dermatology portfolio. |
| 2018-07-27 | Dr. Birnbaum is a pharmacologist and since 1999, has been a consultant to pharmaceutical companies... Education: B.S. in Biology from Trinity College in Connecticut, Ph.D. in Pharmacology from the University of Wisconsin. |
Data sourced from SEC filings. Last updated: 2026-03-14